277 related articles for article (PubMed ID: 25625544)
41. Ethosomes: a potential nanovesicular carrier to enhancing the drug delivery against skin barriers.
Hameed H; Faheem S; Khan MA; Hameed A; Ereej N; Ihsan H
J Microencapsul; 2024 May; 41(3):204-225. PubMed ID: 38456667
[TBL] [Abstract][Full Text] [Related]
42. Hyaluronic acid-containing ethosomes as a potential carrier for transdermal drug delivery.
Xie J; Ji Y; Xue W; Ma D; Hu Y
Colloids Surf B Biointerfaces; 2018 Dec; 172():323-329. PubMed ID: 30176512
[TBL] [Abstract][Full Text] [Related]
43. Enhanced transdermal bioavailability of testosterone propionate via surfactant-modified ethosomes.
Meng S; Chen Z; Yang L; Zhang W; Liu D; Guo J; Guan Y; Li J
Int J Nanomedicine; 2013; 8():3051-60. PubMed ID: 23990718
[TBL] [Abstract][Full Text] [Related]
44. Safety and Antioxidant Efficacy Profiles of Rutin-Loaded Ethosomes for Topical Application.
Cândido TM; De Oliveira CA; Ariede MB; Velasco MVR; Rosado C; Baby AR
AAPS PharmSciTech; 2018 May; 19(4):1773-1780. PubMed ID: 29600391
[TBL] [Abstract][Full Text] [Related]
45. An evaluation of tocotrienol ethosomes for transdermal delivery using Strat-M
Nair RS; Billa N; Leong CO; Morris AP
Pharm Dev Technol; 2021 Feb; 26(2):243-251. PubMed ID: 33274672
[TBL] [Abstract][Full Text] [Related]
46. Skin penetration and deposition of carboxyfluorescein and temoporfin from different lipid vesicular systems: In vitro study with finite and infinite dosage application.
Chen M; Liu X; Fahr A
Int J Pharm; 2011 Apr; 408(1-2):223-34. PubMed ID: 21316430
[TBL] [Abstract][Full Text] [Related]
47. [Study on preparation of testosterone undecanoate ethosomes and its in vitro transdermal penetration].
Meng S; Yang LQ; Ma LY; Guo J; Li M; Yang D
Zhongguo Zhong Yao Za Zhi; 2013 May; 38(9):1371-4. PubMed ID: 23944071
[TBL] [Abstract][Full Text] [Related]
48. Factorial design based curcumin ethosomal nanocarriers for the skin cancer delivery:
Peram MR; Jalalpure S; Kumbar V; Patil S; Joshi S; Bhat K; Diwan P
J Liposome Res; 2019 Sep; 29(3):291-311. PubMed ID: 30526186
[TBL] [Abstract][Full Text] [Related]
49. Deformable liposomes and ethosomes as carriers for skin delivery of ketotifen.
Elsayed MM; Abdallah OY; Naggar VF; Khalafallah NM
Pharmazie; 2007 Feb; 62(2):133-7. PubMed ID: 17341034
[TBL] [Abstract][Full Text] [Related]
50. Combinations of nanovesicles and physical methods for enhanced transdermal delivery of a model hydrophilic drug.
Zorec B; Zupančič Š; Kristl J; Pavšelj N
Eur J Pharm Biopharm; 2018 Jun; 127():387-397. PubMed ID: 29581043
[TBL] [Abstract][Full Text] [Related]
51. Comparative study of liposomes, ethosomes and transfersomes as carriers for enhancing the transdermal delivery of diflunisal: In vitro and in vivo evaluation.
Abd El-Alim SH; Kassem AA; Basha M; Salama A
Int J Pharm; 2019 May; 563():293-303. PubMed ID: 30951860
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of skin inflammation in mice by diclofenac in vesicular carriers: liposomes, ethosomes and PEVs.
Caddeo C; Sales OD; Valenti D; Saurí AR; Fadda AM; Manconi M
Int J Pharm; 2013 Feb; 443(1-2):128-36. PubMed ID: 23299087
[TBL] [Abstract][Full Text] [Related]
53. Intradermal and follicular delivery of adapalene liposomes.
Kumar V; Banga AK
Drug Dev Ind Pharm; 2016; 42(6):871-9. PubMed ID: 27031916
[TBL] [Abstract][Full Text] [Related]
54. Deformable liposomes and ethosomes: mechanism of enhanced skin delivery.
Elsayed MM; Abdallah OY; Naggar VF; Khalafallah NM
Int J Pharm; 2006 Sep; 322(1-2):60-6. PubMed ID: 16806755
[TBL] [Abstract][Full Text] [Related]
55. Transdermal delivery of vancomycin hydrochloride using combination of nano-ethosomes and iontophoresis: in vitro and in vivo study.
Mohammed MI; Makky AM; Teaima MH; Abdellatif MM; Hamzawy MA; Khalil MA
Drug Deliv; 2016 Jun; 23(5):1558-64. PubMed ID: 25726990
[TBL] [Abstract][Full Text] [Related]
56. Ethosomes as Vesicles for Effective Transdermal Delivery: From Bench to Clinical Implementation.
Akhtar N; Varma A; Pathak K
Curr Clin Pharmacol; 2016; 11(3):168-190. PubMed ID: 27526697
[TBL] [Abstract][Full Text] [Related]
57. Development and evaluation of the effect of ethanol and surfactant in vesicular carriers on Lamivudine permeation through the skin.
Sudhakar K; Mishra V; Jain S; Rompicherla NC; Malviya N; Tambuwala MM
Int J Pharm; 2021 Dec; 610():121226. PubMed ID: 34710540
[TBL] [Abstract][Full Text] [Related]
58. Statistically optimised ethosomes for transdermal delivery of tolterodine tartrate.
Prasanthi D; Lakshmi PK
Pak J Pharm Sci; 2013 Nov; 26(6):1117-22. PubMed ID: 24191315
[TBL] [Abstract][Full Text] [Related]
59. Development of nanovesicular systems for dermal imiquimod delivery: physicochemical characterization and in vitro/in vivo evaluation.
Ma M; Wang J; Guo F; Lei M; Tan F; Li N
J Mater Sci Mater Med; 2015 Jun; 26(6):191. PubMed ID: 25989936
[TBL] [Abstract][Full Text] [Related]
60. Flurbiprofen loaded ethosomes - transdermal delivery of anti-inflammatory effect in rat model.
Paliwal S; Tilak A; Sharma J; Dave V; Sharma S; Yadav R; Patel S; Verma K; Tak K
Lipids Health Dis; 2019 Jun; 18(1):133. PubMed ID: 31170970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
